Le Roith D - Search Results

1

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.

Le Roith D. Le Roith D. N Engl J Med. 1997 Feb 27;336(9):633-40. doi: 10.1056/NEJM199702273360907. N Engl J Med. 1997. PMID: 9032050 Review. No abstract available.

2

Non-islet cell hypoglycemia.

LeRoith D. LeRoith D. Ann Endocrinol (Paris). 2004 Feb;65(1):99-103. doi: 10.1016/s0003-4266(04)95641-7. Ann Endocrinol (Paris). 2004. PMID: 15122103 Review.

3

14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.

Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. Zhang Y, et al. J Biol Chem. 2004 Aug 13;279(33):34353-60. doi: 10.1074/jbc.M401300200. Epub 2004 Jun 8. J Biol Chem. 2004. PMID: 15187095

4

Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.

Mosa R, Huang L, Wu Y, Fung C, Mallawakankanamalage O, LeRoith D, Chen C. Mosa R, et al. Endocrinology. 2017 Oct 1;158(10):3174-3187. doi: 10.1210/en.2017-00168. Endocrinology. 2017. PMID: 28977588 Free PMC article.

5

Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D. Yakar S, et al. J Clin Invest. 2004 Jan;113(1):96-105. doi: 10.1172/JCI17763. J Clin Invest. 2004. PMID: 14702113 Free PMC article.

6

Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.

Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clemmons D, Yakar S, LeRoith D. Pennisi P, et al. Endocrinology. 2006 Jun;147(6):2619-30. doi: 10.1210/en.2005-1556. Epub 2006 Mar 2. Endocrinology. 2006. PMID: 16513827

7

Mouse models created to study the pathophysiology of Type 2 diabetes.

LeRoith D, Gavrilova O. LeRoith D, et al. Int J Biochem Cell Biol. 2006;38(5-6):904-12. doi: 10.1016/j.biocel.2005.01.019. Epub 2005 Aug 2. Int J Biochem Cell Biol. 2006. PMID: 16103004 Review.

8

Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM, Reitman ML, Yakar S, Stannard B, Heron-Milhavet L, Wheeler MB, LeRoith D. Kim H, et al. Diabetes. 2003 Jul;52(7):1770-8. doi: 10.2337/diabetes.52.7.1770. Diabetes. 2003. PMID: 12829645

9

The insulin-like growth factor system and cancer.

LeRoith D, Roberts CT Jr. LeRoith D, et al. Cancer Lett. 2003 Jun 10;195(2):127-37. doi: 10.1016/s0304-3835(03)00159-9. Cancer Lett. 2003. PMID: 12767520 Review.

10

The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.

Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclair Y, Leroith D, Rosen CJ. Yakar S, et al. J Endocrinol. 2006 May;189(2):289-99. doi: 10.1677/joe.1.06657. J Endocrinol. 2006. PMID: 16648296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results